| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 1,590 | 1,460 | 1,220 | 1,390 | 1,140 |
| Sales Growth | +8.90% | +19.67% | -12.23% | +21.93% | -22.97% |
| Net Income | -110 | -70 | -400 | -440 | -820 |
| Net Income Growth | -57.14% | +82.50% | +9.09% | +46.34% | -2.50% |
Vycor Medical Inc (VYCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Vycor Medical Inc. designs, develops and markets neurological medical devices and therapies in the United States and Europe. Its operating segment includes Vycor Medical and NovaVision. Vycor Medical Inc. is based in Boca Raton, Florida.
Fiscal Year End Date: 12/31